Safety Information
It’s important to consider that the Visian ICL is FDA approved which means it has been determined to be a safe and effective procedure. As with any procedure, there are risks to consider, if you have any questions or concerns it's always best to speak with a certified Visian ICL doctor. Please view the Patient Information Booklet for full information.
Ready to Discover Visual Freedom With ICL? Find a Doctor Today
This information is presented in the public interest by STAAR Surgical™ to create awareness of options available for those with near-sightedness with or without astigmatism. Please consult your health care provider to determine which option is right for you.
Select Your Region
Latin America
References
1Patient Survey, STAAR Surgical ICL Data Registry, 2018
2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.
3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.